Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Completed 4Suspended 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Congenital Abnormalities 1Breast Neoplasms 1

Interventions

Cyclophosphamide 4Vincristine 3Rituximab 3Prednisone 3zanubrutinib 2Doxorubicin 2tisagenlecleucel 1sargramostim 1prednylidene 1fludarabine 1deltacortene 1brincidofovir 1axicabtagene ciloleucel 1Methods 1Immunotherapy, Active 1Immunization, Passive 1Epirubicin 1E7777 fusion protein 1Drug Therapy 1Coal Tar 1CT-P10 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, Large B-Cell, Diffuse × Epirubicin × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡